Synthego

Synthego company information, Employees & Contact Information

Explore related pages

Related company profiles:

Synthego is a CRISPR solutions provider that enables the acceleration of life science research and development in the pursuit of improved human health. Synthego is a pioneering force in the biotechnology industry, dedicated to advancing the frontiers of CRISPR cell and gene therapies through cutting-edge CRISPR technology and expertise. Our mission is to provide unparalleled access to best-in-class CRISPR solutions at scale, empowering agility in life science research and development from discovery through clinical trials. From streamlined approaches to licensing through full technical and regulatory support from our industry-leading experts, Synthego is enabling greater access to CRISPR technology driving to improved outcomes in patient therapeutic treatments. At Synthego, our values define who we are and how we work together to shape the future of science. Ingenuity drives us to innovate and solve complex challenges in groundbreaking ways. Collaboration fuels our success, as we believe the best ideas come from diverse perspectives working together. Kindness shapes our workplace culture, fostering mutual respect and care for one another. Empowerment inspires every team member to take initiative, grow, and make meaningful contributions. Integrity forms the foundation of everything we do, ensuring trust, transparency, and excellence guide our actions. We believe that fostering an environment of belonging is essential to driving innovation and collaboration. Through our Diversity Network Association (DNA), we actively amplify diverse voices, champion equity, and create spaces where inclusivity thrives. These principles are not just policies or initiatives; they’re integrated into our DNA and guide how we work together every day. By weaving diversity, equity, and inclusion into the fabric of our identity, we strengthen our team, inspire new ideas, and ensure everyone can contribute meaningfully to shaping the future of science.

Company Details

Employees
169
Founded
-
Address
3565 Haven Ave,
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Menlo Park, California
Looking for a particular Synthego employee's phone or email?

Synthego Questions

News

Synthego: Acquisition By Perceptive Advisors Closed - Pulse 2.0

Synthego: Acquisition By Perceptive Advisors Closed Pulse 2.0

Synthego Announces Successful Close of Acquisition by Perceptive Advisors - PR Newswire

Synthego Announces Successful Close of Acquisition by Perceptive Advisors PR Newswire

Case Summary: Synthego Chapter 11 - Bondoro

Case Summary: Synthego Chapter 11 Bondoro

Synthego Signs Strategic Agreement with AstraZeneca to License CRISPR Gene Editing Enzyme - PR Newswire

Synthego Signs Strategic Agreement with AstraZeneca to License CRISPR Gene Editing Enzyme PR Newswire

CRISPR Revolution in Cell and Gene Therapy - Genetic Engineering and Biotechnology News

CRISPR Revolution in Cell and Gene Therapy Genetic Engineering and Biotechnology News

Optimizing CRISPR/Cas9-based gene manipulation in echinoderms - ScienceDirect.com

Optimizing CRISPR/Cas9-based gene manipulation in echinoderms ScienceDirect.com

Synthego and ATCC Enter Alliance for Cutting-Edge Gene Editing of Mammalian and Mouse Cell Lines - BioSpace

Synthego and ATCC Enter Alliance for Cutting-Edge Gene Editing of Mammalian and Mouse Cell Lines BioSpace

Synthetic sgRNA for CRISPR genome editing - News-Medical

Synthetic sgRNA for CRISPR genome editing News-Medical

Software for the Cell & Gene Therapy Wave: Vineti’s Amy DuRoss on The Long Run - Timmerman Report

Software for the Cell & Gene Therapy Wave: Vineti’s Amy DuRoss on The Long Run Timmerman Report

Synthego Launches Powerful CRISPR Analysis Software to Make World-Class Genome Engineering Accessible - Lab Manager

Synthego Launches Powerful CRISPR Analysis Software to Make World-Class Genome Engineering Accessible Lab Manager

Engineering single-cycle MeV vector for CRISPR-Cas9 gene editing - ScienceDirect.com

Engineering single-cycle MeV vector for CRISPR-Cas9 gene editing ScienceDirect.com

Supplement: Analyzing CRISPR Editing Results - Genetic Engineering and Biotechnology News

Supplement: Analyzing CRISPR Editing Results Genetic Engineering and Biotechnology News

A Single Shot for Heart Disease: Sekar Kathiresan on The Long Run - Timmerman Report

A Single Shot for Heart Disease: Sekar Kathiresan on The Long Run Timmerman Report

Synthego Announces CEO Transition to Focus on Enabling CRISPR Therapeutics - PR Newswire

Synthego Announces CEO Transition to Focus on Enabling CRISPR Therapeutics PR Newswire

Investigations into the FLG Null Phenotype: Showcasing the Methodology for CRISPR/Cas9 Editing of Human Keratinocytes - ScienceDirect.com

Investigations into the FLG Null Phenotype: Showcasing the Methodology for CRISPR/Cas9 Editing of Human Keratinocytes ScienceDirect.com

Synthego Launches Express Cell Pools for Faster, More Efficient Genome Editing - PR Newswire

Synthego Launches Express Cell Pools for Faster, More Efficient Genome Editing PR Newswire

Protocol for genomic editing in human resting primary NK cells and NK-92 cells via CRISPR-Cas9 ribonucleoproteins - ScienceDirect.com

Protocol for genomic editing in human resting primary NK cells and NK-92 cells via CRISPR-Cas9 ribonucleoproteins ScienceDirect.com

Synthego Bridges Critical Preclinical Gap to Accelerate CRISPR-based Cell and Gene Therapies - PR Newswire

Synthego Bridges Critical Preclinical Gap to Accelerate CRISPR-based Cell and Gene Therapies PR Newswire

Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-phase Research to the Clinic - PR Newswire

Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-phase Research to the Clinic PR Newswire

Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineering - PR Newswire

Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineering PR Newswire

Generation and immunofluorescent validation of gene knockouts in adult human colonic organoids using multi-guide RNA CRISPR-Cas9 - ScienceDirect.com

Generation and immunofluorescent validation of gene knockouts in adult human colonic organoids using multi-guide RNA CRISPR-Cas9 ScienceDirect.com

Split Decision: Synthego Spins Out EditCo Bio Around Engineered Cell Platform - Genetic Engineering and Biotechnology News

Split Decision: Synthego Spins Out EditCo Bio Around Engineered Cell Platform Genetic Engineering and Biotechnology News

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering - ScienceDirect.com

Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering ScienceDirect.com

ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs - ScienceDirect.com

ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs ScienceDirect.com

CRISPRoff enables spatio-temporal control of CRISPR editing - Nature

CRISPRoff enables spatio-temporal control of CRISPR editing Nature

Non-viral expression of chimeric antigen receptors with multiplex gene editing in primary T cells - Frontiers

Non-viral expression of chimeric antigen receptors with multiplex gene editing in primary T cells Frontiers

Human OX40L–CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity - Science | AAAS

Human OX40L–CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity Science | AAAS

Production of CFTR-ΔF508 Rabbits - Frontiers

Production of CFTR-ΔF508 Rabbits Frontiers

Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology - ScienceDirect.com

Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology ScienceDirect.com

Protocol for generating monoclonal CRISPR-Cas9-mediated knockout cell lines using RNPs and lipofection in HNSCC cells - ScienceDirect.com

Protocol for generating monoclonal CRISPR-Cas9-mediated knockout cell lines using RNPs and lipofection in HNSCC cells ScienceDirect.com

Engineering Biology—Accelerating Transition - Genetic Engineering and Biotechnology News

Engineering Biology—Accelerating Transition Genetic Engineering and Biotechnology News

Uses of CRISPR/Cas Biosensing Systems - News-Medical

Uses of CRISPR/Cas Biosensing Systems News-Medical

The heat is on: a simple method to increase genome editing efficiency in plants - BMC Plant Biology

The heat is on: a simple method to increase genome editing efficiency in plants BMC Plant Biology

Evaluation of ebony as a potential selectable marker for genetic sexing in Aedes aegypti - Parasites & Vectors

Evaluation of ebony as a potential selectable marker for genetic sexing in Aedes aegypti Parasites & Vectors

CRISPR/Cas9 mediated gene editing in non-model nematode Panagrolaimus sp. PS1159 - Frontiers

CRISPR/Cas9 mediated gene editing in non-model nematode Panagrolaimus sp. PS1159 Frontiers

CRISPR/Cas9-mediated tissue-specific knockout and cDNA rescue using sgRNAs that target exon-intron junctions in Drosophila melanogaster - ScienceDirect.com

CRISPR/Cas9-mediated tissue-specific knockout and cDNA rescue using sgRNAs that target exon-intron junctions in Drosophila melanogaster ScienceDirect.com

How CRISPR Is Accelerating Drug Discovery - Genetic Engineering and Biotechnology News

How CRISPR Is Accelerating Drug Discovery Genetic Engineering and Biotechnology News

Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2 - ScienceDirect.com

Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2 ScienceDirect.com

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program - Nature

A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program Nature

7 Gene Editing Companies Investors Should Watch - Nanalyze

7 Gene Editing Companies Investors Should Watch Nanalyze

COVID-19 Treatment Efforts Using Plant Technologies - ISAAA.org

COVID-19 Treatment Efforts Using Plant Technologies ISAAA.org

Understanding the Regulatory Challenges for CRISPR Gene Editing on Crops - FoodEngineeringMag.com

Understanding the Regulatory Challenges for CRISPR Gene Editing on Crops FoodEngineeringMag.com

How Mutations in the PINK1 Gene May Lead to Parkinson's Disease - Healthline

How Mutations in the PINK1 Gene May Lead to Parkinson's Disease Healthline

Top Synthego Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant